Skip to main content
. 2020 Jul 25;9(4):889–911. doi: 10.1007/s40123-020-00280-8

Fig. 1.

Fig. 1

Belamaf structure and mechanism of action. ADC antibody–drug conjugate, ADCC/ADCP antibody-directed cellular cytotoxicity/phagocytosis, BCMA B-cell maturation antigen, IgG1 immunoglobulin G1, mAb Monoclonal antibody, MM multiple myeloma, MMAF monomethyl auristatin F